Technical and clinical aspects of cortisol as a biochemical marker of chronic stress by 김어수
BMB
   Reports
BMB Rep. 2015; 48(4): 209-216
www.bmbreports.org
*Corresponding authors. Eosu Kim, Tel: +82-2-2228-1620; Fax: 
+82-2-318-0891; E-mail: kimeosu@yuhs.ac, Man Ho Choi, Tel: 
+82-2-958-5081, Fax: +82-2-958-5059, E-mail: mh_choi@kist.re.kr
http://dx.doi.org/10.5483/BMBRep.2015.48.4.275
Received 17 October 2014
Keywords: Allostasis, Cortisol, Hair, Mass spectrometry, Metabolo-
mics, Stress
ISSN: 1976-670X (electronic edition)
Copyright ⓒ 2015 by the The Korean Society for Biochemistry and Molecular Biology
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/li-
censes/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Technical and clinical aspects of cortisol as a biochemical 
marker of chronic stress
Do Yup Lee1, Eosu Kim2,* & Man Ho Choi3,*
1Department of Bio and Fermentation Convergence Technology, Kookmin University, Seoul 136-702, 2Department of Psychiatry, Institute 
of Behavioral Science in Medicine, Brain Korea 21 Plus Project for Medical Science, Yonsei University College of Medicine, Seoul 120-752, 
3Future Convergence Research Division, Korea Institute of Science and Technology, Seoul 136-791, Korea
Stress is now recognized as a universal premorbid factor 
associated with many risk factors of various chronic diseases. 
Acute stress may induce an individual’s adaptive response to 
environmental demands. However, chronic, excessive stress 
causes cumulative negative impacts on health outcomes 
through “allostatic load”. Thus, monitoring the quantified 
levels of long-term stress mediators would provide a timely 
opportunity for prevention or earlier intervention of stress- 
related chronic illnesses. Although either acute or chronic 
stress could be quantified through measurement of changes in 
physiological parameters such as heart rate, blood pressure, 
and levels of various metabolic hormones, it is still elusive to 
interpret whether the changes in circulating levels of stress 
mediators such as cortisol can reflect the acute, chronic, or 
diurnal variations. Both serum and salivary cortisol levels 
reveal acute changes at a single point in time, but the overall 
long-term systemic cortisol exposure is difficult to evaluate due 
to circadian variations and its protein-binding capacity. Scalp 
hair has a fairy predictable growth rate of approximately 1 
cm/month, and the most 1 cm segment approximates the last 
month’s cortisol production as the mean value. The analysis of 
cortisol in hair is a highly promising technique for the retro-
spective assessment of chronic stress. [BMB Reports 2015; 
48(4): 209-216]
INTRODUCTION
Stress can lead to both physical and psychological health 
issues. Some stress can be beneficial at times by producing a 
boost that provides the drive and energy to help people get 
through situations like exams or work deadlines. However, an 
extreme amount of stress can lead to negative consequences 
and adversely affect the immune, cardiovascular, neuro-
endocrine, and central nervous systems (1). In particular, chron-
ic stress can have a serious impact due to sustained high levels 
of the chemicals released in the “fight or flight” response, which 
involves endocrine system releasing glucocorticoids (2, 3).
　Cortisol, which is synthesized from cholesterol, is the main 
glucocorticoid in the zona fasciculate of human adrenal 
cortex. Its secretion in response to biochemical stress contrib-
utes to the well-characterized suppression of the hypo-
thalamic-pituitary-adrenal (HPA) axis on health and cognition 
events (4-6). Since the vast majority of cortisol actions rely on 
binding to cytosolic receptors, only a small fraction of un-
bound, free cortisol is revealed to be biologically active. It 
comes out of the mitochondrion, migrates out of the cell into 
the extracellular space and into the bloodstream. Due to its 
low molecular weight and lipophilic nature, unbound cortisol 
enters the cells through passive diffusion, which makes it fea-
sible to measure the free cortisol in many body fluids (7).
　In general, cortisol levels in blood increase during the early 
morning (highest at about 8 a.m.) and decrease slightly in the 
evening and during the early phase of sleep (8). The timing of 
blood sampling is therefore very important. While its assess-
ment in sweat or tears is only of theoretical importance and 
urinary cortisol of decreasing interest, salivary cortisol may 
have some advantages over the assessment of cortisol in blood 
(9, 10). Since the hormone levels in biological fluids fluctuate 
on a daily basis, cortisol extracted from the hair fiber has been 
investigated (11-13). This review discusses on the methods in-
volved in mass spectrometry-based metabolomic studies for 
identification of biomarkers in chronic stress, which is more 
focused on hair cortisol. Comparative statistical analyses of 
crucial aspects are also included to facilitate the understanding 
of recent advances in the metabolic platform on mining 
biomarkers.
STRESS AND THE ADRENAL GLAND
The two adrenal glands are located on top of the kidneys, and 
these glands produce hormones in response to stress. Each 
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Fig. 1. The differential stress hor-
mones secreted by adrenal cortex and 
medullar. Catecholamines cause gen-
eral physiological changes that pre-
pare the body for physical activity 
(fight-or-flight response) in the short- 
term response. Some typical effects in-
clude increases in heart rate, blood 
pressure, and blood glucose levels, 
and other general reactions of the 
sympathetic nervous system. Corticoids 
are involved in a wide range of phys-
iological processes including chronic 
stress response, immune response, and 
regulations of inflammation, carbohy-
drate metabolism, protein catabolism, 
blood electrolyte levels, and behavior. 
Data are taken from “https://www.
studyblue.com/notes/note/n/07-adrenal- 
glands/deck/1109539”.
adrenal gland consists of a central area, called the medulla, 
and an outer area of the cortex (Fig. 1). In case of the apparent 
threat, the hypothalamus sends direct signals via the sym-
pathetic nervous system to the adrenal glands, causing them to 
release a catecholamine and epinephrine (same as adrenaline). 
It leads to an urgent action by stimulating faster breathing and 
heart rates. The adrenal medullar also secrete another cat-
echolamine, norephinephrine, which works with epinephrine 
to stimulate liver cells to release glucose to make more fuel 
available for cellular respiration. These hormones have 
short-term effects as the nerve impulses are sent from the 
hypothalamus. Due to the short half-life of blood catechol-
amine, meticulous care must be taken to obtain blood samples 
consistently vis-à-vis the stress immersion experience (14).
　Finding a “gold standard” biomarker for chronic stress has 
been proven to be challenging, given its complex etiology and 
highly individual manifestations, while the biomarkers of acute 
stress have been well-defined and are primarily used to assess 
the release of catecholamine. Hormones secreted by the adre-
nal cortex provide a slower, longer-acting (chronic) response 
to the stress. In this event, the hypothalamus secretes a releas-
ing hormone which causes the anterior pituitary to secrete an 
adrenal-stimulating hormone, adrenocorticotrophic hormone 
(ACTH); and this signals the cells in the adrenal cortex to pro-
duce and secrete corticosteroids. Among them, mineralocorti-
coids, like aldosterone, can regulate water and sodium re-ab-
sorption in the kidneys. It also regulates the active secretion of 
potassium in the principal cells of the cortical collecting tubule 
and protons via proton ATPases in the luminal membrane of 
the intercalated cells of the collecting tubule, which results in 
an increase of blood pressure and blood volume. Glucocorti-
coids promote fat and protein breakdown and glucose syn-
thesis. Cortisol is the major glucocorticoids, and it regulates or 
supports a variety of important cardiovascular, metabolic, im-
munologic, and homeostatic functions (1).
ALLOSTASIS AND ALLOSTATIC LOAD
The term, stress, was originally adopted from engineering 
(measure of the internal forces induced by deformation of a 
body), but it is now referred to ‘threats or anticipation of 
threats to an organism’s homeostasis’ (15). Thus stress events 
could be understood as any stimuli that cause alterations in 
homeostasis for adaptation to the environment. These changes 
in homeostasis are referred to as ‘allostasis’, which can be ex-
emplified by increased heart rate or blood pressure and en-
hanced systemic metabolism. In general, allostasis can be 
adaptive or maladaptive depending on its degree or contextual 
relevance; mediators of allostasis, such as metabolic hor-
mones, could contribute to healthy adaptation and pathophysi-
ology (16). The concept of ‘allostatic load’ indicates an altered, 
‘new set point’ of homeostasis, resulting from cumulative ef-
fects of allostatic responses which are chronic, excessive, or 
poorly regulated (15, 16). For example, the increased serum 
glucose level is responsible for a single acute stressful event, 
which can be called as ‘allostatic response’. Also, diabetes 
(insulin resistance) resulting from repetitive chronic stress can 
be understood as an ‘allostatic overload’, in which the base-
line fasting glucose level has been newly set to a higher level 
than before (Fig. 2). Therefore, the biomarkers of allostatic 
 Metabolic biomarkers in chronic stress
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Fig. 2. Stress, allostasis, and allostatic load. Stress is any stimulus 
inducing either adaptive or maladaptive allostasis (changes in ho-
meostasis) of stress mediators, which constitute the autonomic 
nervous system (blood pressure, catecholamines), metabolic hor-
mones (cortisol, insulin), and pro- & anti-inflammatory cytokines. 
If stress stimuli are excessive and repetitive, recovery to the origi-
nal homeostatic levels may be incomplete (indicated by the sec-
ond blue arrow). As a result, chronic stress can make a body sys-
tem to anticipate, as if such a new (stressful) environment would 
persist, demanding a newly defined set point for future adap-
tation. Thus, the difference between the new and old set points 
can be understood as a ‘cumulative burden of adaptation to 
stress’- i.e., allostatic load. Examples of allostatic load may be 
found in the primary mediators (hypercortisolemia, increased infla-
mmatory cytokines), secondary outcomes (elevated blood pressure, 
overweight, insulin resistance), or tertiary outcomes (hypertension, 
diabetes, obesity, coronary heart disease, neurodegenerative dis-
orders). For more details, see reference # 6.
load, if available, could be used for measuring and predicting 
the cumulative biological risks of impending illnesses, and 
they are ideal indicators for detecting the ‘pre-phase’ of ill-
nesses (6, 17, 18).
　Mediators of allostasis constitute the autonomic nervous sys-
tem (catecholamines), metabolic hormones, and various cyto-
kines (15, 16). Among these, cortisol is the one that has been 
paid great attention based on the concept of ‘glucocorticoid 
cascade hypothesis’ (19). This hypothesis explains how and 
why the cortisol actions could be related to pathophysiology 
upon overload of stress. Psychological and physical stresses in-
crease the circulating cortisol levels. In the acute state, in-
creased cortisol induces adaptive responses via enhancing ca-
tabolic processes to supply more energy to the body. In gen-
eral, increased cortisol levels return to the basal levels by feed-
back inhibition mechanisms through the hypothalamus, pre-
frontal cortex, and most importantly, hippocampus (20). When 
stressful stimuli are repeated chronically, circulating cortisol is 
maintained at higher levels over a prolonged period. Chronically 
elevated cortisol levels now causes damages on hippocampal 
and cortical neurons (19), which are the main regions where 
the feedback inhibition starts. As a result, even when stress 
stimuli disappear, cortisol levels could be maintained at higher 
levels beyond the physiologically normal range due to a vicious 
cycle caused by the already damaged feedback mechanism.
　Consequently, a great number of studies have explored the 
potential of utilizing cortisol as a biomarker for various chronic 
illnesses or their pre-disease states (21, 22). Currently, it seems 
that such role of cortisol, as one of biomarkers for the allostatic 
load, may be largely accepted (6). However, there are still con-
troversial issues regarding the sampling and measurement 
methods of these hormones that are fluctuated by environ-
mental contexts as well as by the circadian cycle. However, 
the most important issues might be the possibility that the level 
measured once at a current point could reflect the past history 
of an individual’s stress load, just as HbA1c indicating the de-
gree of ‘glucose load’ for the past 3 months. The level of corti-
sol in scalp hair is now considered as a promising biomarker 
for assessing the averaged level of one’s past stress burden dur-
ing a given period, and it will be further discussed in this 
paper. Its utility has been demonstrated across diverse clinical 
settings from neonates to old age, indicated by associations of 
hair cortisol levels with babies’ stress in the neonatal intensive 
care unit (23), children’s stress at school entry (24), and vari-
ous metabolic and neuropsychiatric disorders including acute 
myocardial infarction (25), heart failure (26), metabolic syn-
drome (27), and post-traumatic stress disorder (28).
ADVANCES IN CORTISOL DETECTION IN 
METABOLITE PROFILING
Because more than 90% of circulating cortisol in human se-
rum is protein-bound, changes in the binding proteins can al-
ter the levels of serum total cortisol without influencing the 
free concentrations of cortisol. Total cortisol could be mislead-
ingly lower than anticipated, resulting in the incorrect inter-
pretation that adrenal function is impaired. This is important 
because the current standards for defining normal adrenal 
functions are based on healthy people who have normal levels 
of binding proteins. Measuring serum free cortisol levels in 
critical illnesses may help to prevent the unnecessary use of 
glucocorticoid therapy (21). Although the free cortisol hypoth-
esis has been widely used, it has also been suggested that cor-
tisol binding globulin (CBG)-bound cortisol may have physio-
logical effects on target tissues (22).
　There is a high correlation between salivary cortisol levels 
and unbound cortisol in plasma and serum, which remains 
high during the circadian cycle and under different dynamic 
test such as ACTH stimulation (22, 29). Since free cortisol rep-
resents the biologically active hormone fraction, salivary corti-
sol measures have early been considered as a better method 
than serum cortisol for the evaluation of adrenocortical func-
tion (9). Recently, the late-night salivary cortisol has been 
showing a superior diagnostic performance as the primary bio-
chemical diagnostic test for Cushing’s syndrome (10). Cortisol 
in biological fluids has been extensively evaluated with corti-
sone, which may reveal the activity of 11-hydroxysteroid de-
hydrogenase (11-HSD) by mass spectrometry-based metabo-
lite profiling techniques (30-32). These analytical methods 
have shown the acceptable analytical sensitivity and the se-
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Fig. 3. A proposed mechanism of cortisol incorporation into hair 
and retrospective reflection of its chronic secretion. Cortisol may 
be incorporated into hair via passive diffusion from (A) blood ca-
pillary, (B) sweat, and (C) sebum, as well as from (D) external 
sources. Data are taken from reference #12.
lectivity in trace amounts of biological samples such as urine 
and serum. However, the methods have still hampered from 
incorrect physiological levels of adrenal steroids, including 
cortisol, due to the sampling problems with circadian 
variation. In general, acute cortisol levels fluctuate markedly 
depending on many physiological factors including circadian 
rhythmicity, and it may provide a rather poor reflection of nor-
mal, chronic cortisol secretion (12, 13).
　 In contrast to the biological fluids, hair can provide bio-
logical information of long-term exposure because its growth 
rate is about 1 cm/month (Fig. 3). The hormones are mainly 
delivered from the blood circulation to the capillaries of the 
dermal papilla, which is located in the hair follicles (33). This 
phenomenon enables retrospective examination of cortisol 
production at the times when a stressor is most salient, without 
needing to take a sample right at that time. Alternatively, it can 
provide a baseline cortisol assessment for a time period during 
which the stress has not yet occurred. In addition, its non-in-
vasive nature in sampling and easy storage at room temper-
ature has been highlighted as advantage in clinical applica-
tions (34-36). In the hair analysis, steroid hormones are ex-
tracted by solubilization or digestion of the hair matrix with al-
kaline hydrolysis for androgen and estrogens (37, 38). Also, 
the acid hydrolysis or methanol extraction can enable an anal-
ysis of corticoids in hair due to its insufficient chemical stabil-
ity (11). When 62 biologically active steroids were analyzed 
by an optimized extraction technique, and only 20 hair ste-
roids, including cortisol and cortisone, were quantitatively de-
tectable (11).
STRESS-MEDIATED HAIR CORTISOL IN ENDOCRINE 
SYSTEM
Because more than 70% of diseases are believed to be 
stress-related, prediction of chronic stress is an important step 
in reducing the incidence of chronic illnesses. Hair cortisol 
may provide an objective measurement of stress over time 
rather than just ‘a day in life’. The symptoms of the metabolic 
syndrome resemble those of Cushing’s syndrome, a disease 
that is characterized by hypercortisolism. One of the questions 
raised is whether chronically elevated cortisol concentrations 
play a role in the development of obesity and the metabolic 
syndromes. The increased hair cortisol levels are also asso-
ciated with children’s obesity caused by long-term activation 
of HPA-axis (39), which is in accordance with the urinary lev-
els of cortisol in obese children (40). The risk of cardiovascular 
disease (CVD) is associated with the increase in hair cortisol 
levels by 2.7-times, which was similar to the risk associated with 
hypertension or obesity. This suggests that high cortisol levels in 
a long-term might be an important risk factor for CVD (41).
　Mitotane, an anti-neoplastic agent for adrenocortical cancer 
(ACC), increases CBG and induces CYP3A4 activity, which 
leads to high doses of hydrocortisone; however, there has 
been no efficient biomarker to evaluate this therapy. Hair corti-
sol levels were higher in ACC patients compared to healthy in-
dividuals, and they were associated with body mass index 
(42). However, there was no correlation between hair cortisol 
levels and hydrocortisone doses. As a measure of long-term 
cortisol exposure, the hair cortisol analysis in patients receiv-
ing glucocorticoid replacement therapy may be a useful tool. 
Also, the hair cortisol content is correlated with hydro-
cortisone dose in the patients with adrenal insufficiency, who 
had significantly higher subjective stress scores than the con-
trol subjects (43). 
METABOLOMIC IDENTIFICATIONS IN CHRONIC 
STRESS
The main benefit of metabolomic strategy is the high like-
lihood of identifying unpredicted changes in metabolic profiles 
cued by abnormal conditions (44). In particular, the metab-
olomic information may offer novel diagnostic indicators and 
therapeutic targets in clinical applications (45), as well as in 
mechanistic studies heading to elucidate metabolic modules that 
can regulate dysfunctional processes in disease statuses (46).
　Among dysfunctional heath conditions, chronic diseases are 
mostly composed of subtle and long-term dysregulations of 
cellular and physiological function that is often not measurable 
even during disease onset (47). The stress-inducing abnormal 
status is chronically developed with unpredictable combina-
tion of various types of etiological factors. Therefore, the mo-
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Fig. 4. Reconstructed metabolic net-
work for systematic screening of ther-
apeutic target point. The re-modeled 
metabolic structure is composed of 
metabolites, which consists of node 
(e.g. metabolite) and edge (e.g. corre-
lation, structural similarity). The model 
may be extended to protein infor-
mation via reaction pair that has al-
ready been built in the assembly, 
which could unravel “hidden” or veiled 
metabolic modulation, particularly in 
chronic disease. In this example, node 
color and size indicate significant dif-
ference and fold change compared to 
control (e.g. disease vs control), while 
edge presents two layers of informa-
tion on structural similarity and re-
action likelihood, which leads to auto-
matic rearrangement as seen in the 
figure indicating proximity of bioche-
mical module.
lecular characterization as well as clinical definition may not 
be clear at specific disease course and it may not be homolo-
gous across individuals (48). The diversity of pathological traits 
induced by chronic stress make it even harder to properly di-
agnose the abnormality and classify the progress stage. Most of 
the studies are mainly focused on targeted single molecule and 
one-point interaction, which may be insufficient to reflect the 
dynamics and systematic effects of chronic stress (49). In this 
context, metabolite profiling can be an effective tool for bio-
marker discovery and understanding of molecular mechanism, 
particularly for the cases where a diagnostic/prognostic in-
dicator is unknown and molecular mechanism remains veiled. 
Recently, a chronic unpredictable mild stress in animal model 
showed aberrant profiling of amino acids that were grouped 
into neurotransmitters and branched-chain amino acids (50). 
The metabolic signatures under acute and chronic stress in rat 
model and the biochemical cues are also closely associated 
with behavior and physiological readouts (49).
DATA MINING IN METABOLOMICS
To capture disease-specific metabolic signatures, many studies, 
including the case studies described above, primarily explored 
on the multiple molecular constituents (metabolites), robustly 
managed variability and heterogeneity of disease progress, and 
defined the individuality of metabolic contents, which could 
lead to well-defined diagnoses and prognoses. In this context, 
multivariate statistics such as principal component analysis 
(PCA) or partial least squared algorithm is a useful data mining 
tool that can distinguish different groups with minimized loss 
of information (51). By this nature, unidentified variation 
source caused by transient (time-course) or individual specific-
ity can be handled within reconstructed statistical model, 
which in turn offers more robust candidates for diagnostic/ 
prognostic information in clinical cases (Fig. 4).
　In many studies, metabolomic approach has been limitedly 
applied to biomarker discovery with either single target or 
group of metabolites. Yet, an ideal exploratory use of the tech-
nology would not only be able to capture the metabolite 
changes associated with pathology, but it would also elucidate 
the molecular mechanism responsible for the dysfunction and 
propose the logical candidate for regulating the abnormality. 
Pathway (enrichment) analysis, a systematic approach for data 
mining from metabolite sets, can provide metabolic path-
way-wise information rather than the readouts of individual or 
few metabolite contents (52). This bioinformatics tool, which 
is rooted in gene ontology enrichment analysis, assigns groups 
of metabolites at the level of metabolic pathway. The analysis 
provides P value that presents significant difference at the lev-
els of metabolic pathways and information on pathway cen-
trality (pathway importance), which demonstrates how much 
connectivity is formed surrounding the metabolites of interest 
in the pathway (53). The output can be further investigated for 
mechanistic understanding of disease, and it can be applied 
for targeting and controlling the functional points of disease 
process. However, although metabolic signature can be identi-
fied at the level of either single molecule, groups of metabo-
lites, or metabolic pathway, metabolite assessment cannot by 
itself provide a complete understanding of disease process. To 
gain comprehensive causality and mechanism in given ex-
perimental designs, integrative analysis should be accom-
panied by other molecular information such as mRNA ex-
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pression levels and protein abundances (54). Since metab-
olomics joins systems with biology, mRNA has been the first 
partner for integrative analysis mainly due to the well-estab-
lishment of technical platform and advancements in statistical 
analysis. However, the expression level of mRNA showed a 
low correlation with enzyme activity and protein expression 
levels, which is a direct molecular companion with metabo-
lites, the substrate, and products. Thus protein information is 
more suitable counterpart of metabolite readout (55).
　Most importantly, in order to have molecular information 
(mRNA, protein, and metabolite) located at the cornerstone of 
clinical application, various types of molecular levels should 
be linked to physiological traits (e.g. clinical parameter) in a 
statistically sound manner. This has been mainly done by 
‘qualitative’ assessment in which the final readout of molec-
ular behaviors is linked to logical phenotypes of disease. For 
example, aberrant glycolytic activity can be associated with tu-
mor metabolism, in which glycolytic intermediates and key 
enzymes are overexpressed in tumor cells. But in the case of 
chronic disease, we may not be able to detect “the stand-
ardized feature” like cancer metabolism case. Alternatively, 
we can track and correlate the quantitative traits of pathology 
with molecular dynamics, which can bear the variability 
caused by individuality and differential disease progress. One 
relevant statistical approach is canonical correlation analysis 
(CCA), which has been often applied in psychological, cli-
mate, and ecological studies to enumerate the correlations be-
tween two distinct data sets measured on the identical ex-
perimental units (56-59). This statistics can analyze significant 
relations between two different dataset (e.g. metabolite con-
tents and the associated clinical parameters). It is similar as 
PCA, in the way that CCA seeks for linear combinations of the 
variables to reduce the dimension of the data sets; but at the 
same time, it explores to maximize the correlation between 
the two variates (58).
CONCLUDING REMARKS
Because single cortisol assessments are strongly affected by the 
acute context of the measurement situation (time of day, day 
of the week, and other circumstances such as distress for 
blood sampling), the assessment of long-term cortisol secretion 
from the biological fluids, such as blood, urine, and saliva, is 
highly labor-intensive and rather difficult to be implemented in 
physical and psychological studies. Hair growth patterns also 
vary across different regions of the scalp, and the precise 
mechanisms of substances incorporating into hair are still in-
completely understood. But a growing observation supports 
the notion that hair cortisol analysis provides a valid and reli-
able reflection of long-term cortisol secretion (12, 13, 27). We 
mainly discussed about the advantages of hair analysis as an 
index of chronic cortisol response. Due to their association 
with various aspects of biochemical stress in adrenal steroids 
and other steroid metabolites, advantages of hair analysis may 
not only be restricted to cortisol (35). Further research on es-
tablishing the reference values of hair cortisol may be needed 
to enhance the current knowledge on particular aspects of 
chronic stress and other metabolic changes in many endocrine 
diseases.
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